4597.T
Price:
$31
Market Cap:
$7.93B
Solasia Pharma K.K. develops and commercializes drugs in the field of oncology in Japan and other Asian countries. The company offers SP-03 (episil oral liquid) for the protection and relief of oral pain associated with oral mucositis/stomatitis caused by chemotherapy and radiotherapy for cancer; and SP-01 (Sancuso), a transdermal delivery system that delivers granisetron, an anti-emetic into the patient's bloodstream for the treatment of chemotherapy induced nausea and vomiting. It is also developing SP-02 (Darinaparsin), a mitochondrial-targeted agent that has completed phase III clinical study to treat various hematologic and solid cancers; and SP-04 a chemotherapy induced peripheral neur...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2017-03-27
Stock Exchange
JPX
Ticker
4597.T
According to Solasia Pharma K.K.’s latest financial reports and current stock price. The company's current Enterprise Value is 6.20B. This represents a change of -15.53% compared to the average of 7.34B of the last 4 quarters.
The mean historical Enterprise Value of Solasia Pharma K.K. over the last ten years is 12.80B. The current 6.20B Enterprise Value has changed 4.74% with respect to the historical average. Over the past ten years (40 quarters), 4597.T's Enterprise Value was at its highest in in the December 2017 quarter at 31.10B. The Enterprise Value was at its lowest in in the March 2016 quarter at 0.
Average
12.80B
Median
10.50B
Minimum
6.29B
Maximum
28.97B
Discovering the peaks and valleys of Solasia Pharma K.K. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 229.87%
Maximum Annual Enterprise Value = 28.97B
Minimum Annual Increase = -67.95%
Minimum Annual Enterprise Value = 6.29B
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 6.29B | -8.80% |
| 2023 | 6.90B | 3.24% |
| 2022 | 6.68B | -49.75% |
| 2021 | 13.30B | 13.52% |
| 2020 | 11.71B | -23.50% |
| 2019 | 15.31B | 64.87% |
| 2018 | 9.29B | -67.95% |
| 2017 | 28.97B | 229.87% |
| 2016 | 8.78B | -57.72% |
| 2015 | 20.77B | -0.25% |
The current Enterprise Value of Solasia Pharma K.K. (4597.T) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
6.62B
5-year avg
8.98B
10-year avg
12.80B
Solasia Pharma K.K.’s Enterprise Value is greater than MedRx Co., Ltd (4.84B), less than Morishita Jintan Co., Ltd. (9.10B), less than Data Horizon Corporation (8.40B), greater than Modalis Therapeutics Corporation (1.42B), greater than Chordia Therapeutics Inc. (4.83B), less than ADR120S, Inc. (6.95B), greater than SymBio Pharmaceuticals Limited (3.03B), greater than BrightPath Biotherapeutics Co., Ltd. (3.37B), less than Chiome Bioscience Inc. (6.56B), greater than OncoTherapy Science, Inc. (5.46B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 4.84B | $6.59B | |
| 9.10B | $8.85B | |
| 8.40B | $6.38B | |
| 1.42B | $4.46B | |
| 4.83B | $7.38B | |
| 6.95B | $7.32B | |
| 3.03B | $4.78B | |
| 3.37B | $4.63B | |
| 6.56B | $7.48B | |
| 5.46B | $7.11B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Solasia Pharma K.K. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Solasia Pharma K.K. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Solasia Pharma K.K.'s Enterprise Value?
What is the highest Enterprise Value for Solasia Pharma K.K. (4597.T)?
What is the 3-year average Enterprise Value for Solasia Pharma K.K. (4597.T)?
What is the 5-year average Enterprise Value for Solasia Pharma K.K. (4597.T)?
How does the current Enterprise Value for Solasia Pharma K.K. (4597.T) compare to its historical average?